Minimally Invasive Surgery for Gastric Cancer: The Future Standard of Care

2011 ◽  
Vol 35 (7) ◽  
pp. 1469-1477 ◽  
Author(s):  
Keisuke Koeda ◽  
Satoshi Nishizuka ◽  
Go Wakabayashi
Keyword(s):  
Gastric Cancer ◽  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
Standard Of Care ◽  
The Future

scholarly journals Current status of minimally invasive surgery for gastric cancer: A literature review to highlight studies limits

2015 ◽  
Vol 17 ◽  
pp. 34-40 ◽  
Author(s):  
Amilcare Parisi ◽  
Ninh T. Nguyen ◽  
Daniel Reim ◽  
Shu Zhang ◽  
Zhi-Wei Jiang ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Minimally Invasive Surgery ◽  
Literature Review ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
Current Status

scholarly journals Difficult Decisions in Minimally Invasive Surgery of the Thymus

Cancers ◽  
2021 ◽  
Vol 13 (23) ◽  
pp. 5887
Author(s):  
Ankit Dhamija ◽  
Jahnavi Kakuturu ◽  
J. W. Awori Hayanga ◽  
Alper Toker
Keyword(s):  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Myasthenia Gravis ◽  
Invasive Surgery ◽  
Early Stage ◽  
Disease Process ◽  
Standard Of Care ◽  
Prognostic Importance

A minimally invasive resection of thymomas has been accepted as standard of care in the last decade for early stage thymomas. This is somewhat controversial in terms of higher-staged thymomas and myasthenia gravis patients due to the prognostic importance of complete resections and the indolent characteristics of the disease process. Despite concerted efforts to standardize minimally invasive approaches, there is still controversy as to the extent of excision, approach of surgery, and the platform utilized. In this article, we aim to provide our surgical perspective of thymic resection and a review of the existing literature.

scholarly journals Long Term Survival and Quality of Life after Minimally Invasive Surgery for Early Gastric Cancer.

1998 ◽  
Vol 31 (4) ◽  
pp. 1015-1019
Author(s):  
Tetsuro Kubota ◽  
Yoichiro Ishikawa ◽  
Soichiro Isshiki ◽  
Takeyoshi Yokoyama ◽  
Koji Fujita ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Gastric Cancer ◽  
Minimally Invasive Surgery ◽  
Early Gastric Cancer ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
Term Survival ◽  
Long Term Survival

The future of imaging in minimally invasive surgery

2000 ◽  
Vol 14 (6) ◽  
pp. 518-519
Author(s):  
S. Vetter ◽  
A. Park ◽  
W. F. Charash ◽  
M. Shaw
Keyword(s):  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
The Future

scholarly journals Utilization of Minimally Invasive Surgery and Its Association with Chemotherapy for Locally Advanced Gastric Cancer

2019 ◽  
Vol 24 (2) ◽  
pp. 243-252
Author(s):  
Rhami Khorfan ◽  
Cary Jo R. Schlick ◽  
Anthony D. Yang ◽  
David D. Odell ◽  
David J. Bentrem ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Advanced Gastric Cancer ◽  
Invasive Surgery ◽  
Locally Advanced ◽  
Locally Advanced Gastric Cancer

scholarly journals Minimally invasive surgery in thymic malignances: the new standard of care

2018 ◽  
Vol 10 (S14) ◽  
pp. S1666-S1670 ◽  
Author(s):  
Xuefei Zhang ◽  
◽  
Zhitao Gu ◽  
Wentao Fang
Keyword(s):  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
Standard Of Care

scholarly journals Implementing complete mesocolic excision for colon cancer – mission completed?

2018 ◽  
Vol 3 (1) ◽  
pp. 17-29 ◽  
Author(s):  
Roland S. Croner ◽  
Henry Ptok ◽  
Susanne Merkel ◽  
Werner Hohenberger
Keyword(s):  
Colon Cancer ◽  
Minimally Invasive Surgery ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
Complete Mesocolic Excision ◽  
Oncological Outcome ◽  
Standard Of Care ◽  
Published Data ◽  
Mesocolic Excision ◽  
Related Survival

AbstractThe definition of complete mesocolic excision (CME) for colon carcinomas revolutionized the way of colon surgery. This technique conquered the world starting from Erlangen. Nevertheless, currently new developments especially in minimally invasive surgery challenge CME to become settled as a standard of care. To understand the evolution of CME, anatomical details occurring during embryogenesis and their variations have to be considered. This knowledge is indispensable to transfer CME from an open to a minimally invasive setting. Conventional surgery for colon cancer (non-CME) has a morbidity of 12.1–28.5% and a 3.7% mortality risk vs. 12–36.4% morbidity and 2.1–3% mortality for open CME. The morbidity of laparoscopic CME is between 4 and 31% with a mortality of 0.5–0.9%. In robotic assisted surgery, morbidity between 10 and 25% with a mortality of 1% was published. The cancer-related survival after 3 and 5 years for open CME is respectively 91.3–95% and 90% vs. 87% and 74% for non-CME. For laparoscopic CME the 3- and 5-year cancer-related survival is 87.8–97% and 79.5–80.2%. In stage UICC III the 3- and 5-year cancer-related survival is 83.9% and 80.8% in the Erlangen data of open technique vs. 75.4% and 65.5–71.7% for laparoscopic surgery. For stage UICC III the 3- and 5-year local tumor recurrence is 3.8%. The published data and the results from Erlangen demonstrate that CME is safe in experienced hands with no increased morbidity. It offers an obvious survival benefit for the patients which can be achieved solely by surgery. Teaching programs are needed for minimally invasive CME to facilitate this technique in the same quality compared to open surgery. Passing these challenges CME will become the standard of care for patients with colon carcinomas offering all benefits of minimally invasive surgery and oncological outcome.

Sign in / Sign up

Export Citation Format

Share Document